Glomerular and tubular function in glycogen storage disease

被引:27
|
作者
Lee, PJ [1 ]
Dalton, RN [1 ]
Shah, V [1 ]
Hindmarsh, PC [1 ]
Leonard, JV [1 ]
机构
[1] INST CHILD HLTH,LONDON CTR PAEDIAT ENDOCRINOL & METAB,INT GROWTH RES CTR,LONDON,ENGLAND
关键词
glycogen storage disease; hyperfiltration; proteinuria; hypercalciuria; tubular function;
D O I
10.1007/BF00868717
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Urinary protein and calcium excretion were assessed in 77 patients with the hepatic glycogen storage diseases (GSD): 30 with GSD-I (median age 12.4 years, range 3.2-32.9 years), 25 with GSD-III (median age 10.5 years, range 4.2-31.3 years) and 22 with GSD-IX (median age 11.8 years, range 1.2-35.4 years). Inulin (C-inulin) and para-aminohippuric acid (C-PAH) clearances were also measured in 33 of these patients. Those with GSD-I had significantly greater albumin (F=15.07, P < 0.001), retinol-binding protein (REP) (F=14.66, P<0.001), N-acetyl-beta-D-glucosaminidase (NAG) (F=9.41, P<0.001) and calcium (F=7.41, P=0.001) excretion than those with GSD-III and GSD-IX. GSD-I patients (n=18) also had significantly higher C-inulin (F=5.57, P=0.009), but C-PAH did not differ (F=0.77, NS). Renal function was normal in GSD-UI and GSD-IX patients. In GSD-I, C-inulin (r=-0.51, P=0.03) and NAG excretion (r=-0.40, P=0.03) were inversely correlated with age, whereas albumin excretion was positively correlated with age (r=+0.41, P=0.03). REP and calcium excretion were generally high throughout all age groups. Hyperfiltration in GSD-I is associated with renal tubular proteinuria that occurs before the onset of significant albuminuria. Deficiency of glucose-6-phosphatase within the proximal renal tubule may primarily cause tubular dysfunction, glomerular hyperfiltration being a secondary phenomenon.
引用
收藏
页码:705 / 710
页数:6
相关论文
共 50 条
  • [31] GLYCOGEN-STORAGE DISEASE-I AND HEPATOCELLULAR TUMORS
    BIANCHI, L
    EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 : S63 - S70
  • [32] Oral Giant Cell Granuloma in a Patient with Glycogen Storage Disease
    do Amaral, Fabricio Rezende
    Carvalho, Vinicius Magalhaes
    Fraga, Marina Guimaraes
    Pimenta Amaral, Tania Mara
    Gomes, Carolina Cavalieri
    Gomez, Ricardo Santiago
    OPEN DENTISTRY JOURNAL, 2009, 3 : 144 - 146
  • [33] A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase
    Maile, C. A.
    Hingst, J. R.
    Mahalingan, K. K.
    O'Reilly, A. O.
    Cleasby, M. E.
    Mickelson, J. R.
    McCue, M. E.
    Anderson, S. M.
    Hurley, T. D.
    Wojtaszewski, J. F. P.
    Piercy, R. J.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (01): : 3388 - 3398
  • [34] Activation of glycolysis and apoptosis in glycogen storage disease type Ia
    Sun, Baodong
    Li, Songtao
    Yang, Liu
    Damodaran, Tirupapuliyur
    Desai, Dev
    Diehl, Anna Mae
    Alzate, Oscar
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2009, 97 (04) : 267 - 271
  • [35] Efficacy of magnetic resonance imaging in managing glycogen storage disease
    Ahn, Jhii-Hyun
    Jeong, Yong Whi
    Choi, Yong Bok
    Kang, Yunkoo
    ORPHANET JOURNAL OF RARE DISEASES, 2025, 20 (01)
  • [36] Disturbed lipid metabolism in glycogen storage disease type 1
    Bandsma, RHJ
    Smit, GPA
    Kuipers, F
    EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (Suppl 1) : S65 - S69
  • [37] Clinical profile and outcome of glycogen storage disease in Indian children
    Poojari, Vishrutha
    Shah, Ira
    Shetty, Naman S.
    Mirani, Sonal
    Tolani, Drishti
    TROPICAL DOCTOR, 2021, 51 (02) : 189 - 192
  • [38] RELIABILITY OF HISTOLOGICAL CRITERIA IN GLYCOGEN-STORAGE-DISEASE OF THE LIVER
    JEVON, GP
    FINEGOLD, MJ
    PEDIATRIC PATHOLOGY, 1994, 14 (04): : 709 - 721
  • [39] CARDIOMYOPATHY OF GLYCOGEN-STORAGE-DISEASE TYPE-III
    CARVALHO, JS
    MATTHEWS, EE
    LEONARD, JV
    DEANFIELD, J
    HEART AND VESSELS, 1993, 8 (03) : 155 - 159
  • [40] FDG PET/CT in Type I Glycogen Storage Disease
    Manca, Chloe
    Claudin, Marine
    Belle, Arthur
    Marie, Pierre Yves
    Verger, Antoine
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (04) : E200 - E201